The company has other products already, and even other new products in the pipeline, so the company has a certain value even if the latest expectation all are waiting for at the moment shouldn't pass the FDA approval etc... I mean thought logically...why is that unrealistic?
The decision (presentation of the data for this new drug product against Alzheimer disease) will fall mid November as stated in the FDA calendar (cf. link in posting #3 by CET above and search therein for CRTX).
Last edited:
Currently doing stocks only with a mini acct, boring... :-(